tolbutamide has been researched along with Pseudohypoparathyroidism in 2 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Pseudohypoparathyroidism: A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yasuda, K | 1 |
Hurukawa, Y | 1 |
Okuyama, M | 1 |
Kikuchi, M | 1 |
Yoshinaga, K | 1 |
Fichman, MP | 1 |
Brooker, G | 1 |
2 other studies available for tolbutamide and Pseudohypoparathyroidism
Article | Year |
---|---|
Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release.
Topics: Calcium; Glucose Tolerance Test; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypopa | 1975 |
Deficient renal cyclic adenosine 3'-5' monophosphate production in nephrogenic diabetes insipidus.
Topics: Adult; Chromatography, Ion Exchange; Cyclic AMP; Diabetes Insipidus; Diuresis; Female; Glucagon; Hum | 1972 |